Ann: Creso Pharma Announces Three New Board Appointments, page-61

OK, so you're going back to that side of the argument ......... it's like ping-pong !

Last Quarter was 1.8 million in Revenue & 5.1 million in Expenses (round numbers) - not the ratio that you have stated - so I'm calling BS on your numbers Pinocchio.

It's the next couple of Quarters that will be of particular interest to investors.

As for your last question - ask the people who have funnelled their capital into the company in the last few days and brought the price up over 12%.